Virvio Company

Developer of a broadly-protective influenza therapeutic.
Technology: Early Drug Development
Industry: Early Drug Development
Headquarters: Seattle, Washington, United States
Founded Date: 2015-12-01
Employees Number: 1-10
Investors Number: 1
Total Funding: 209000
Estimated Revenue: Less than $1M
Last Funding Date: 2016-02-15
Last Funding Type: Grant

Visit Website
info@virvio.com
Register and Claim Ownership